Accessing Cell and Gene Therapies: Insights on Coverage, Rei

Editor’s Note: In a new white paper, summarized below, Manatt Health discusses emerging reimbursement models for cell and gene therapies. The paper provides an overview of current...

Related Keywords

United States , American , Americans , Phelps Phillips , Scott Gottlieb , Peter Marks , Medicaid Budget Survey For State Fiscal Years , Manatt Health , Program Administration , American Society Of Gene , Medicare Program , Medicaid Drug Rebate Program , Centers For Medicare Medicaid Services , Drug Administration , Medicaid Program , National Drug Rebate Agreement , Gene Therapy , Medicaid Services , Gene Therapy Access Model , New Technology Add On Payments , Prospective Payment System , Medicaid Innovation , Magellan Rx Medical Pharmacy Report , Biologics Evaluation , Executive Order , Lowering Prescription Drug Costs , Cell Therapy , Social Security Act , Program Integrity Updates Under , Medicaid Drug Rebate , Hospital Inpatient Prospective Payment Systems , Acute Care Hospitals , Policy Changes , Fiscal Year , Equality Programs , Eligible Hospitals , Critical Access Hospitals , Costs Incurred , Non Qualified Deferred Compensation Plans , Critical Access Hospital Conditions , Pandemic Continues , Shape Medicaid Priorities , Annual Medicaid Budget Survey , State Fiscal Years ,